Gilead Sciences, Inc.(GILD)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
GILD | 194.07 B | - | 10.20% | -10.64% | -$2.82 | -20.68% | 2.23x | 2.05% | $160.51 | $114.02 |
950160.KQ | 1.31 T | - | - | - | - | - | - | - | $149000.00 | $11470.00 |
ABBV | 510.84 B | 78.98x | 10.20% | 9.80% | $3.66 | - | - | 2.41% | $291.40 | $188.25 |
950220.KQ | 57.50 B | - | 4559.30% | 0.00% | - | -61.03% | 0.20x | - | $4450.00 | $1115.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Gilead Sciences, Inc. (GILD) compared to its primary competitors (including 950160.KQ, ABBV, 950220.KQ) reveals distinct metrics. GILD trades at a valuation discount relative to its competitors, with a P/E ratio of -55.5x versus the peer average of 79.0x (representing a 170% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, GILD's revenue growth of 10.2% lags behind the peer average of 2284.8%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -10.6% is below the peer average of 4.9%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• GILD ranks #0 in P/E ratio, #2 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $154.73 | $155.41 | $151.71 | $153.57 | 6,188,210 | -1.88% |
| 2026-10-20 | $155.37 | $157.48 | $154.02 | $156.51 | 5,792,500 | +2.25% |
| 2026-10-19 | $155.39 | $157.24 | $152.92 | $153.07 | 6,834,600 | -2.00% |
| 2026-10-16 | $157.32 | $157.58 | $155.62 | $156.19 | 7,770,900 | -0.75% |
| 2026-10-15 | $156.39 | $160.51 | $156.02 | $157.37 | 8,287,500 | +2.49% |
| 2026-10-14 | $148.19 | $153.76 | $147.48 | $153.54 | 5,756,500 | +3.80% |
| 2026-10-13 | $151.16 | $151.16 | $147.26 | $147.92 | 5,558,100 | -1.67% |
| 2026-10-12 | $151.84 | $152.26 | $149.80 | $150.43 | 5,791,400 | -0.49% |
| 2026-10-09 | $147.23 | $151.44 | $146.10 | $151.17 | 5,802,000 | +2.77% |
| 2026-10-08 | $146.73 | $147.59 | $144.65 | $147.10 | 4,489,500 | +0.17% |
| 2026-10-07 | $145.28 | $148.60 | $144.85 | $146.85 | 5,096,700 | +1.82% |
| 2026-10-06 | $145.11 | $146.14 | $142.60 | $144.23 | 3,723,400 | -0.28% |
| 2026-10-05 | $143.21 | $145.16 | $142.79 | $144.63 | 6,137,600 | -0.08% |
| 2026-10-02 | $147.65 | $148.00 | $144.00 | $144.74 | 5,043,900 | -1.87% |
| 2026-10-01 | $149.44 | $149.44 | $147.19 | $147.50 | 4,438,500 | -1.04% |
Explore More Analysis for GILD
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.